Purpose The study aims to assess the feasibility of intensity-modulated and image-guided radiotherapy (IMRT, and IGRT, respectively) for functional preservation in locally advanced laryngeal cancer. A retrospective review of 27 patients undergoing concurrent chemoradiation for locally advanced laryngeal cancers (8 IMRT, 19 IGRT) was undertaken. In addition to regular clinical examinations, all patients had PET imaging at 4 months and 10 months after radiotherapy, then yearly. Loco-regional control, speech quality and feeding-tube dependency were assessed during follow-up visits. Results At a median follow-up of 20 months (range 6–57 months), four out of 27 patients (14.8%) developed local recurrence and underwent salvage total laryngectomy. One patient developed distant metastases following salvage surgery. Among the 23 patients who conserved their larynx with no sign of recurrence at last follow-up, 22 (95%) reported normal or near normal voice quality, allowing them to communicate adequately. Four patients (14.8%) had long-term tube feeding-dependency because of severe dysphagia (2 patients) and chronic aspiration (2 patients, with ensuing death from aspiration pneumonia in one patient). Conclusions and Clinical Relevance Functional laryngeal preservation is feasible with IMRT and IGRT for locally advanced laryngeal cancer. However, dysphagia and aspiration remain serious complications, due most likely to high radiation dose delivery to the pharyngeal musculatures.
References
[1]
Tupchong L, Scott CB, Blitzer PH, Marcial VA, Lowry LD, et al. (1991) Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study. Int J Radiat Oncol Biol Phys 20: 21–28.
[2]
DeSanto LW, Olsen KD, Perry WC, Rohe DE, Keith RL (1995) Quality of life after surgical treatment of cancer of the larynx. Ann Otol Rhinol Laryngol 104: 763–769.
[3]
Deshmane VH, Parikh HK, Pinni S, Parikh DM, Rao RS (1995) Laryngectomy: a quality of life assessment. Indian J Cancer 32:121: 130.
[4]
Hilgers FJ, Ackerstaff AH, Aaronson NK, Schouwenburg PF, Van Zandwijk N (1990) Physical and psychosocial consequences of total laryngectomy. Clin Otolaryngol 15: 421–425.
[5]
Kuntz AL, Weymuller EA (1999) Impact of neck dissection on quality of life. Laryngoscope 8: 1334–1338.
[6]
Rogers SN, Lowe D, Brown JS, Vaughan ED (1999) The University of Washington head and neck cancer measure as a predictor of outcome following primary surgery for oral cancer. Head Neck 21: 394–401.
[7]
Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared to surgery plus radiation in patients with advanced laryngeal cancer: The department of veterans affair laryngeal cancer study group (1991). N Engl J Med 324: 1685–1690.
[8]
Forastiere AA, Goepfert H, Maor M, et al. (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349: 2091–2098.
[9]
Lefebvre JL, Rolland F, Tesselaar M, Bardet E, Leemans CR, et al. (2009) Phase III randomized trial on larynx preservation comparing sequential and alternating chemotherapy and radiotherapy. J Nat Cancer Inst 101: 142–152.
[10]
Posner MR, Norris CM, Wirth LJ, Shin DM, Cullen KJ, et al. (2009) Sequential therapy for the locally advanced larynx and hypopharyngeal cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol 20: 921–927.
[11]
Sanguineti G, Adapala P, Endres EJ, Brack C, Fiorino C, et al. (2007) Dosimetric predictors of laryngeal edema. Int J Radiat Oncol Biol Phys 68: 741–749.
[12]
Nguyen NP, Moltz CC, Frank C, Vos P, Millar C, et al. (2007) Aspiration rate following nonsurgical therapy for laryngeal cancer. ORL 69: 116–120.
[13]
Braaksma MMJ, Wijers OB, van Sornsen de Koste JR, van der Est H, Schmitz PI, et al. (2003) Optimisation of conformal radiation therapy by intensity-modulation: cancer of the larynx and salivary function. Radiother Oncol 66: 291–302.
[14]
Zevallos JP, Mallen MJ, Lam CY, Karam-Hage M, Blalock J, et al. (2009) Complications of radiotherapy in laryngopharyngeal cancer. Effects of a smoking cessation program. Cancer 115: 4636–4644.
[15]
Liberman PHP, Schultz C, Gomez VSG, Carvalho AL, Pelizzon AC, et al. (2004) Auditory effects after organ preservation protocol for laryngeal/hypopharyngeal carcinomas. Arch Otolaryngol Head Neck Surg 130: 1265–1268.
[16]
Nguyen NP, Vock C, Chi A, Ewell L, Vos P, et al. (2012) Effectiveness of intensity-modulated and image-guided radiotherapy to spare the mandible from excessive radiation. Oral Oncol 48: 653–657.
[17]
Nguyen NP, Smith-Raymond L, Vinh-Hung V, Sloan D, Davis R, et al. (2011) Feasibility of Tomotherapy to spare the cochlea from excessive radiation in head and neck cancer. Oral Oncol 47: 900–904.
[18]
Nguyen NP, Vos P, Vinh-Hung V, Ceizyk M, Smith-Raymond L, et al.. (2012) Feasibility of image-guided radiotherapy based on helical tomotherapy to reduce contralateral parotid dose in head and neck cancer. BMC Cancer, epublication.
[19]
Penagaricano JA, Ratanatharathorn V, Papanikolaou N, Yan Y (2004) Intensity-modulated radiation therapy reduces the dose to the normal tissue in T2N0M0 squamous cell carcinoma of the glottic larynx. Dosimetry 29: 254–257.
[20]
Dogan N, King S, Emami B, Mohideen N, Mirkovic N, et al. (2003) Assessment of different IMRT delivery methods on target coverage and normal tissue sparing. Int J Radiat Oncol Biol Phys 57: 1480–1491.
[21]
Chen AM, Farwell DG, Luu Q, Chen LM, Vijayakumar S, et al. (2011) Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 80: 1423–1429.
[22]
Gordin A, Daitzchman M, Doweck I, Yefremov N, Golz A, et al. (2006) Fluorodeoxyglucose-Positron emission Tomography/Computed Tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on management. Laryngoscope 116: 273–278.
[23]
Salaun PY, Abgral R, Querellou S, Couturier O, Valette G, et al. (2007) Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up? Head Neck 29: 1125–1130.
[24]
Oe A, Kawabe J, Torii K, Kawamura E, Kotani J, et al. (2006) Detection of local residual tumor after laryngeal cancer treatment using FDG-PET. Ann Nucl Med 21: 9–13.
[25]
Brouwer J, de Bree R, Comans EFI, Akarriou M, Langendijk JA, et al. (2008) Improved detection of recurrent laryngeal tumor FDG-PET as initial method. Radiother Oncol 87: 217–220.
[26]
van Hooren ACG, Brouwer J, de Bree R, Hoekstra OS, Leemans CR, et al. (2009) The cost effectiveness of FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy. Eur Arch Otorhinolaryngol 266: 1441–1448.
[27]
Ward PD, Calcaterra TC, Kagan AR (1975) The enigma of post-radiation edema and residual or recurrent carcinoma of the larynx and pyriform fossa. Laryngoscope 85: 522–529.
[28]
Brouwer J, bogar EJ, de Bree R, Langendijk JA, Castelijns JA, et al. (2004) Detecting recurrent laryngeal carcinoma after radiotherapy: room for improvement. Eur Arch Otorhinolaryngol 261: 417–422.
[29]
Zbaren P, Caversaccio M, Thoeny HC, Nuyens M, Curshmann J, et al. (2006) Radionecrosis or tumor recurrence after radiation of laryngeal hypopharyngeal carcinomas. Otolaryngol Head Neck Surg 135: 838–843.
[30]
Lee NY, O'Meara W, Chan K, Della-Bianca C, Mechalakos JG, et al. (2007) Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys 60: 459–468.
[31]
Studer G, Peponi E, Kloeck S, Dossenbach T, Huber G, et al. (2010) Surviving hypopharynx-larynx carcinoma in the era of IMRT. Int J Radiat Oncol Biol Phys 77: 1391–1396.
[32]
Caglar HB, Tishler RB, Othus M, Burke E, Li Y, et al. (2008) Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 72: 1110–1118.
[33]
Nguyen NP, Moltz CC, Frank C, Vos P, Millar C, et al. (2007) Aspiration rate following nonsurgical therapy for laryngeal cancer. ORL 69: 116–120.
[34]
Hutcheson KA, Barringer DA, Rosenthal DI, May AH, Roberts DB, et al. (2008) Swallowing outcomes after radiotherapy for laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 134: 178–183.
[35]
Nguyen NP, Moltz CC, Frank C, Millar C, Smith HJ, et al. (2007) Effectiveness of the cough reflex in patients with aspiration following radiation for head and neck cancer. Lung 185: 243–248.
[36]
Nguyen NP, Smith HJ, Dutta S, Alfieri A, North D, et al. (2007) Aspiration occurrence during chemoradiation for head and neck cancer. Anticancer Res 27: 1669–1672.
[37]
Clark CH, Bidmead MA, Mubata CD, Harrington KJ, Nutting CM (2004) Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx. Radiother Oncol 70: 189–198.
[38]
Nguyen NP, Moltz CC, Frank C, Smith HJ, Nguyen PD, et al. (2007) Impact of swallowing therapy on aspiration rate following treatment for locally advanced head and neck cancer. Oral Oncol 43: 352–357.
[39]
Buntzel J, Glatzel M, Mucke R, Micke O, Bruns F (2007) Influence of amifostine on late radiation-toxicity in head and neck cancer—a follow-up study. Anticancer Res 2007 27: 1953–1956.
